"MEDEZE" Presented to VI Investors, Showcasing Its Potential as a Leader in Stem Cells and Biotech in Thailand
Dr. Veerapol Khemarangsan (4th from left), Chief Executive Officer; Ms. Supakarn Kitchakosol (3rd from left), Chief Accounting and Financial Officer; Mr. Pipat Pisanuwongruk (2nd from right), Chief Accounting and Financial Officer of MEDEZE Treasury PTE. LTD.; Ms. Danita Phithaknetikun (4th from right), Chief Business Development Officer; Assoc. Prof. Dr. Paiboon Sereewiwattana (3rd from right), Financial Planning Advisor; and Dr. Jeevatra Tanchai (2nd from left), Independent Director/Audit Committee Member of MEDEZE Group Public Company Limited (MEDEZE), participated in an investor presentation.
MEDEZE, a leading provider of stem cell analysis, isolation, cultivation, and storage services, as well as immune cell (NK Cell) potential evaluation, showcased its strong business fundamentals to value investors from the Value Investment Association (Thailand). Also present was Mr. Payuphat Mahaphon (1st from left), Managing Director of Investment Banking at Yuanta Securities (Thailand) Co., Ltd., acting as the financial advisor and underwriter.
The event, organized by the Value Investment Association in collaboration with MEDEZE Group Public Company Limited, was held at Ballroom 1, 5th Floor, S31 Sukhumvit Hotel.
IR Press Releases